Search results
Found 1078 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Chan Zuckerberg Initiative funding awarded to build a globally inclusive musculoskeletal map
General Research
12 November 2021
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) researchers and several international collaborators have been awarded funding from the Chan Zuckerberg Initiative to deliver an ancestrally diverse musculoskeletal atlas of healthy tissues.
Ebola vaccine to begin human trials
Clinical Trials General Research
11 November 2021
The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers – with the first vaccinations having already taken place.
New advanced analytics research to deliver next level of insights into COVID-19
Coronavirus COVID-19 General Research
11 November 2021
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.
Sustainable eating is cheaper and healthier - Oxford study
General Research
11 November 2021
Global study shows vegan and vegetarian diets cheapest option in high-income countries ‘£1 Chef’ Miguel Barclay backs study
Researchers uncover gene that doubles risk of death from COVID-19
Coronavirus COVID-19 General Research
8 November 2021
Scientists at Oxford University have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, partly explaining the excess deaths seen in some UK communities, and the impact of COVID-19 in the Indian subcontinent.
Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders
General Research
5 November 2021
An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.
Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK
General Innovation Research
5 November 2021
Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
General Research
3 November 2021
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
Oxford to work with Brazil to establish clinical research hub
General Research
2 November 2021
The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.
PTSD in healthcare workers during pandemic could be exacerbated by past trauma
Coronavirus COVID-19 General Research
29 October 2021
While some of the high rates of post-traumatic stress (PTSD) seen in healthcare workers during the pandemic are specifically COVID-19-related, a more significant number of cases were linked to trauma that occurred earlier in their lives, researchers at the University of Oxford have found.
Oxford researchers test potential treatment for fatigue in long COVID patients
Clinical Trials Coronavirus COVID-19 General Research
29 October 2021
Radcliffe Department of Medicine researcher Dr Betty Raman is leading a new phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID. The drug, AXA1125, is developed by the US-based biotechnology company Axcella Therapeutics.
Major new research network to investigate the body clock and stroke
General Research
29 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body’s internal clock and the disordered physiological processes associated with stroke.
Wearing face coverings protected wearers from COVID-19 infection – large scale study
Coronavirus COVID-19 General Research
28 October 2021
People who wore face coverings or masks outside of the home, and were more exposed to infection due to their circumstances, had ‘significantly’ lower rates of COVID-19 infection, according to research published in BMJ Open today, led by Oxford’s Leverhulme Centre for Demographic Science.
Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s
General Research
26 October 2021
A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.
Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis
General Research
26 October 2021
Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.
Oxford researchers awarded funding to complete community COVID-19 antiviral trial
Coronavirus COVID-19 General Research
26 October 2021
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
New therapeutic targets identified to treat inflammatory bowel disease
General Research
22 October 2021
Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.
Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile
General Research
22 October 2021
A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.
Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age
General Research
21 October 2021
A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.